Skip to main content

Table 4 Donor information for the validation set

From: Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2

Casea Age Sex Disease Stageb
T6 58 F Pancreatic adenocarcinoma IV
T7 53 M Pancreatic adenocarcinoma III
T8 64 M Pancreatic adenocarcinoma II
T9 51 M Pancreatic adenocarcinoma III
T10 64 F Pancreatic adenocarcinoma III
T11 81 M Pancreatic adenocarcinoma III
T12 59 M Pancreatic adenocarcinoma II
T13 63 M Pancreatic adenocarcinoma III
T14 69 M Pancreatic adenocarcinoma III
T15 48 M Pancreatic adenocarcinoma III
T16 67 M Pancreatic adenocarcinoma IV
T17 56 M Pancreatic adenocarcinoma IV
T18 37 F Pancreatic adenocarcinoma III
T19 58 F Pancreatic adenocarcinoma III
T20 52 F Pancreatic adenocarcinoma IV
T21 62 F Pancreatic adenocarcinoma I
N6 45 F Serous cystic pancreatic neoplasm  
N7 54 F Somatostatin cell tumor  
N8 60 M Islet cell tumor  
N9 54 M Mucinous cystic pancreatic neoplasm  
N10 36 M Pseudocyst  
N11 36 F Serous cystic pancreatic neoplasm  
N12 70 M Pseudocyst  
N13 53 M Pancreatitis  
N14 59 F Pancreatitis  
N15 50 F Chronic pancreatitis  
N16 48 F Intraductal papillary mucinous neoplasm  
N17 37 F Normal  
N18 54 M Normal  
N19 64 M Normal  
N20 72 M Normal  
N21 56 F Normal  
  1. a T: pancreatic cancer patients; N: non-cancer bearing donors.
  2. b The Union International Contre Le Cancer(UICC) classification.